Genmab | GEN - Market Capitalization

Stock Price
1,714.50
Daily Change
12.00 0.70%
Monthly
-12.23%
Yearly
22.51%
Q1 Forecast
1,614.31

Genmab reported DKK109.15B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Almirall EUR 2.66B 102.29M Mar/2026
Amarin USD 341M 4M Sep/2025
Amgen USD 176.25B 24.32B Dec/2025
argenx SE USD 38.95B 12.88B Mar/2026
AstraZeneca USD 288.15B 55.08B Dec/2025
Bayer EUR 36.89B 535.42M Mar/2026
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Demant DKK 46.01B 10.48B Dec/2025
Exelixis USD 11.75B 959M Dec/2025
Fresenius Medical Care EUR 11.68B 275.81M Mar/2026
Galapagos EUR 1.89B 49.73M Mar/2026
Genmab DKK 80.88B 7.82B Jun/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
GN Store Nord DKK 16.11B 98.09M Dec/2025
GRIFOLS EUR 4.43B 3.06B Mar/2026
Hikma Pharmaceutical USD 2.92B 1.72B Mar/2026
Insmed USD 37.12B 6.68B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.3B 6B Mar/2026
Novartis USD 265.66B 9.48B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025